(“Ananda” or the “Company”)
The directors of
Ananda owns 15% of
As previously announced, the hapac® product was launched in
• hapac® continues to be sold in 6 stores in
• hapac® products have been launched online on the Easyjoint e-shop
• A new range of products have been developed and launched
• Sales have increased significantly since
• Plans are in place to launch a www.haplondon.com website and e-shop and further expand distribution.
Further information on the hapac® product can be found at http://hapac.tech
The directors of the Company accept responsibility for the contents of this announcement.
Ananda Developments PLC+44 (0)7392 696 517 firstname.lastname@example.org Chief Executive Officer Melissa SturgessInvestor Relations Jeremy Sturgess-Smith Peterhouse Capital Limited+44 (0)20 7469 0930 Corporate Finance Mark Anwyl Fungai NdoroCorporate Broking Lucy Williams Duncan Vasey
Notes to editors
Ananda Developments invests in the developing market for medical or therapeutic Cannabis derivatives, or related products, including but not limited to nutraceuticals, dietary supplements and cosmetic products which contain Cannabis or hemp derived cannabinoids. The Directors believe that this market is growing due to an increasing number of states in the
A copy of the Company’s Admission Document is available at www.anandadevelopments.com
Ananda’s investment strategy is to invest in companies, projects or products that are progressing medical or therapeutic Cannabis research and development, or seeking to produce or cultivate Cannabis in any jurisdiction in which it is legal to do so, or are developing or have already developed, products that contain Cannabis derived cannabinoids and require funding to progress work plans or commercialise products.